The Impact of Culture Isolation ofAspergillusSpecies: A Hospital‐Based Survey of Aspergillosis
Top Cited Papers
Open Access
- 1 December 2001
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (11), 1824-1833
- https://doi.org/10.1086/323900
Abstract
The term “aspergillosis” comprises several categories of infection: invasive aspergillosis; chronic necrotizing aspergillosis; aspergilloma, or fungus ball; and allergic bronchopulmonary aspergillosis. In 24 medical centers, we examined the impact of a culture positive for Aspergillus species on the diagnosis, risk factors, management, and outcome associated with these diseases. Most Aspergillus culture isolates from nonsterile body sites do not represent disease. However, for high-risk patients, such as allogeneic bone marrow transplant recipients (60%), persons with hematologic cancer (50%), and those with signs of neutropenia (60%) or malnutrition (30%), a positive culture result is associated with invasive disease. When such risk factors as human immunodeficiency virus infection (20%), solid-organ transplantation (20%), corticosteroid use (20%), or an underlying pulmonary disease (10%) are associated with a positive culture result, clinical judgment and better diagnostic tests are necessary. The management of invasive aspergillosis remains suboptimal: only 38% of patients are alive 3 months after diagnosis. Chronic necrotizing aspergillosis, aspergilloma, and allergic bronchopulmonary aspergillosis have variable management strategies and better short-term outcomes.This publication has 70 references indexed in Scilit:
- Refinements of Environmental Assessment During an Outbreak Investigation of Invasive Aspergillosis in a Leukemia and Bone Marrow Transplant UnitInfection Control & Hospital Epidemiology, 2000
- Aspergillus fumigatusand AspergillosisClinical Microbiology Reviews, 1999
- Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlationMedical Mycology, 1998
- Analysis of compassionate use itraconazole therapy for invasive aspergillosis by the NIAID Mycoses Study Group criteriaArchives of Internal Medicine, 1997
- Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infectionJournal of Antimicrobial Chemotherapy, 1997
- Chronic Invasive Aspergillosis in Apparently Immunocompetent HostsClinical Infectious Diseases, 1997
- Trends in the postmortem epidemiology of invasive fungal infections at a University HospitalJournal of Infection, 1996
- NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosisAmerican Journal Of Medicine, 1994
- Epidemiology of invasive aspergillosis in European cancer centresEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- 10 year review of invasive aspergillosis detected at necropsy.Journal of Clinical Pathology, 1991